BRPI0923859A2 - Nanopartícula, composição, métodos para a produção das nanopartículas e de uso, e, uso de nanopartículas. - Google Patents

Nanopartícula, composição, métodos para a produção das nanopartículas e de uso, e, uso de nanopartículas.

Info

Publication number
BRPI0923859A2
BRPI0923859A2 BRPI0923859-0A BRPI0923859A BRPI0923859A2 BR PI0923859 A2 BRPI0923859 A2 BR PI0923859A2 BR PI0923859 A BRPI0923859 A BR PI0923859A BR PI0923859 A2 BRPI0923859 A2 BR PI0923859A2
Authority
BR
Brazil
Prior art keywords
nanoparticle
nanoparticles
composition
methods
production
Prior art date
Application number
BRPI0923859-0A
Other languages
English (en)
Inventor
Robert Edgar Colborn
Peter John Bonitatibus
Andrew Soliz Torres
Michael Ernest Marino
Matthew David Butts
Amit Kulkarni
Brian C Bales
Bruce Allan Hay
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/344,606 external-priority patent/US8728529B2/en
Priority claimed from US12/344,608 external-priority patent/US8574549B2/en
Priority claimed from US12/344,604 external-priority patent/US20100166664A1/en
Application filed by Gen Electric filed Critical Gen Electric
Publication of BRPI0923859A2 publication Critical patent/BRPI0923859A2/pt
Publication of BRPI0923859B1 publication Critical patent/BRPI0923859B1/pt
Publication of BRPI0923859B8 publication Critical patent/BRPI0923859B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A61K49/0428—Surface-modified nanoparticles, e.g. immuno-nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
    • A61K49/1848—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule the small organic molecule being a silane
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
BRPI0923859A 2008-12-29 2009-12-18 composição de agente de diagnóstico, e, método para a produção das nanopartículas BRPI0923859B8 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12/344604 2008-12-29
US12/344,606 US8728529B2 (en) 2008-12-29 2008-12-29 Nanoparticle contrast agents for diagnostic imaging
US12/344608 2008-12-29
US12/344606 2008-12-29
US12/344,608 US8574549B2 (en) 2008-12-29 2008-12-29 Nanoparticle contrast agents for diagnostic imaging
US12/344,604 US20100166664A1 (en) 2008-12-29 2008-12-29 Nanoparticle contrast agents for diagnostic imaging
PCT/EP2009/067468 WO2010076237A2 (en) 2008-12-29 2009-12-18 Nanoparticle contrast agents for diagnostic imaging

Publications (3)

Publication Number Publication Date
BRPI0923859A2 true BRPI0923859A2 (pt) 2015-07-28
BRPI0923859B1 BRPI0923859B1 (pt) 2020-09-15
BRPI0923859B8 BRPI0923859B8 (pt) 2022-10-25

Family

ID=42246275

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923859A BRPI0923859B8 (pt) 2008-12-29 2009-12-18 composição de agente de diagnóstico, e, método para a produção das nanopartículas

Country Status (11)

Country Link
EP (1) EP2379118B1 (pt)
JP (1) JP6063627B2 (pt)
KR (2) KR20170059491A (pt)
CN (2) CN102333547A (pt)
AU (1) AU2009334868B2 (pt)
BR (1) BRPI0923859B8 (pt)
CA (1) CA2748408C (pt)
ES (1) ES2647567T3 (pt)
MX (1) MX2011007058A (pt)
RU (1) RU2526181C2 (pt)
WO (1) WO2010076237A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101276693B1 (ko) * 2010-10-29 2013-06-19 포항공과대학교 산학협력단 양쪽성 이온을 가진 나노입자 표면 개질용 표면 분자체의 합성과 그 응용
JP5790346B2 (ja) * 2011-02-10 2015-10-07 信越化学工業株式会社 アミノ酸変性シラン化合物の製造方法
KR20130045647A (ko) * 2011-10-26 2013-05-06 한국기초과학지원연구원 양쪽성 이온으로 코팅된 자기공명영상 조영제
EP2887969B1 (en) * 2012-08-23 2018-08-01 General Electric Company Nanoparticulate compositions for diagnostic imaging
TWI689310B (zh) 2014-07-11 2020-04-01 巨生生醫股份有限公司 治療鐵缺乏症之方法
RU2582870C2 (ru) * 2014-07-16 2016-04-27 Акционерное общество "Государственный Ордена Трудового Красного Знамени научно-исследовательский институт химии и технологии элементоорганических соединений" (АО "ГНИИХТЭОС") Способ получения ферромагнитных металлических наночастиц с твердой изоляционной оболочкой
CA2961358C (en) * 2014-09-15 2023-08-01 Massachusetts Institute Of Technology Nanoparticles for magnetic resonance imaging applications
WO2016167097A1 (ja) * 2015-04-15 2016-10-20 株式会社Kri ベタイン系ケイ素化合物及びその製造方法並びに親水性コーティング組成液及びコーティング膜
JP2017226759A (ja) * 2016-06-22 2017-12-28 株式会社Kri 修飾金属酸化物ゾル及び親水性コーティング組成物
JP6531124B2 (ja) * 2016-10-07 2019-06-12 株式会社Kri スルホベタイン系ケイ素系化合物の製造方法
WO2018070734A1 (ko) * 2016-10-14 2018-04-19 서울대학교산학협력단 코어쉘 구조를 포함하는 조영 효과 및 조직 접착 특성을 가지는 표지물질 및 이의 제조방법
US11389550B2 (en) * 2017-06-28 2022-07-19 Riken Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound
US20190001001A1 (en) * 2017-07-03 2019-01-03 General Electric Company Drug design for application-dependent payload, controlled pharmacokinetic distribution, and renal clearance
JP7091129B2 (ja) * 2018-04-27 2022-06-27 キヤノン株式会社 粒子、及びその製造方法
JPWO2020138404A1 (ja) 2018-12-27 2021-11-18 アステラス製薬株式会社 親水性リガンドが１つ以上配位結合した酸化鉄を含有する金属粒子を含む、ナノ粒子の製造方法
CN111450258B (zh) * 2019-01-21 2022-08-02 沈阳药科大学 一种促进蛋白药物跨黏液渗透的口服给药系统及其制备
KR20220139330A (ko) * 2020-01-14 2022-10-14 리이스 사인버그 금속-기반 코어 나노입자, 합성 및 사용

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101080240A (zh) * 2004-12-17 2007-11-28 皇家飞利浦电子股份有限公司 用于分子成象和治疗的靶向造影剂或靶向治疗剂
US7462446B2 (en) * 2005-03-18 2008-12-09 University Of Washington Magnetic nanoparticle compositions and methods
US20070292688A1 (en) * 2005-08-18 2007-12-20 Eastman Kodak Company Silylamine modified nanoparticulate carriers
US20070098640A1 (en) * 2005-11-02 2007-05-03 General Electric Company Nanoparticle-based imaging agents for X-ray/computed tomography
US20070122620A1 (en) * 2005-11-02 2007-05-31 General Electric Company Nanoparticle-based imaging agents for x-ray / computed tomography and methods for making same
US20070140974A1 (en) * 2005-12-15 2007-06-21 General Electric Company Targeted nanoparticles for magnetic resonance imaging
WO2007146680A1 (en) * 2006-06-06 2007-12-21 Florida State University Research Foundation , Inc. Stabilized silica colloid
TWI321133B (en) * 2006-08-01 2010-03-01 Univ Kaohsiung Medical Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol)
WO2009047587A1 (en) * 2007-10-12 2009-04-16 Ecole Polytechnique Federale De Lausanne (Epfl) Magnetic, paramagnetic and/or superparamagnetic nanoparticles

Also Published As

Publication number Publication date
EP2379118B1 (en) 2017-10-18
JP6063627B2 (ja) 2017-01-18
KR20110107329A (ko) 2011-09-30
AU2009334868B2 (en) 2015-11-05
CN107029250A (zh) 2017-08-11
AU2009334868A1 (en) 2011-07-07
KR20170059491A (ko) 2017-05-30
WO2010076237A2 (en) 2010-07-08
EP2379118A2 (en) 2011-10-26
CN107029250B (zh) 2023-08-08
CA2748408C (en) 2018-12-04
WO2010076237A3 (en) 2011-02-03
CN102333547A (zh) 2012-01-25
KR101999853B1 (ko) 2019-07-12
BRPI0923859B8 (pt) 2022-10-25
ES2647567T3 (es) 2017-12-22
CA2748408A1 (en) 2010-07-08
RU2526181C2 (ru) 2014-08-20
JP2012513963A (ja) 2012-06-21
BRPI0923859B1 (pt) 2020-09-15
RU2011126275A (ru) 2013-02-10
MX2011007058A (es) 2011-07-28

Similar Documents

Publication Publication Date Title
BRPI0923859A2 (pt) Nanopartícula, composição, métodos para a produção das nanopartículas e de uso, e, uso de nanopartículas.
BRPI1011346A2 (pt) partícula de polímero, composição tensoativa, processos de formação de partículas de polímero, e, uso das mesmas
BRPI0923509A2 (pt) método para produzir nanopartículas de metal e nanopartículas obtidas desta maneira e uso das mesmas.
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
BRPI0913990A2 (pt) complexos de metal de transição de piridildiamido, produção e uso deste
BRPI0822825A2 (pt) Implemento para cuidado oral, e, método para formar um implemento para cuidado oral
BRPI0821858A2 (pt) Composto, composição para cuidado oral, e, método
BR112012000882A2 (pt) Preparação cosmética capilar e método para aplicação.
BRPI0908352A2 (pt) Processo para produzir estruturas porosas, estrutura porosa, e, uso da mesma
BRPI0913447A2 (pt) composição de éster, e, composição para cuidado pessoal.
BRPI0906611A2 (pt) Produtos implantáveis compreendendo nanopartículas.
BRPI0912221A2 (pt) método para produzir nanofibras inorgânicas.
BRPI1014700A2 (pt) composição de revestimento e método para a fabricação e uso da mesma.
BRPI1014850A2 (pt) cosmético em pó e método para produção do mesmo.
FI20085213A (fi) Pigmenttipartikkelikoostumus, menetelmä sen valmistamiseksi sekä sen käyttö
FI20086253A (fi) Sieniendoglukanaasit, niiden valmistus ja käyttö
BRPI0817198A2 (pt) (ciclopropilfenil)feniloxalamidas, método para a produção das mesmas, e uso das mesmas como um medicamento
BR112012032962A2 (pt) composição para utilização em um furo de poço, composição em gel para utilização em um furo de poço, e método.
BRPI1014606A2 (pt) Maltotriosil transferase, processo para produção e uso da mesma
BR112012020579A2 (pt) processo para obtenção de partículas de filossilicatos com tamanho controlado, produto e uso do produto.
BRPI0911554A2 (pt) Microemulsão, processo para a preparação de uma microemulsão, e, uso da microemulsão.
BR112012000530A2 (pt) uso de uma população de nanopartículas metálicas, e, composição farmacêutica.
BRPI1010617A2 (pt) uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição.
EP2295374A4 (en) FULLEREN SILICON DIOXIDE NANOPARTICLES WITH IMPROVED FLUORESCENCE, METHOD FOR THE PRODUCTION THEREOF AND THE APPLICATION THEREOF
BR112012003679A2 (pt) catalisador bi-camada, o respectivo processo de preparo e a respectiva utilização para a fabricação de nanotubos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/12/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B25A Requested transfer of rights approved

Owner name: GE HEALTHCARE LIMITED (GB)